Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2020-10-22 | Dr. Kostas has a B.S from Massachusetts Institute of Technology (MIT) and a M.D. from University of Texas Southwestern Medical School. He is a Partner and Senior Managing Director at Sarissa Capital Management LP, focusing on improving strategies of companies to enhance shareholder value. |
| 2021-02-26 | Odysseas D. Kostas, M.D. (Director) |
| 2021-04-21 | Odysseas D. Kostas, M.D. has served as a member of our Board of Directors since February 2020. He is a Partner and Senior Managing Director at Sarissa Capital Management LP and has a B.S from Massachusetts Institute of Technology (MIT) and a M.D. from University of Texas Southwestern Medical School. He was selected as a director because of his extensive leadership experience with biotechnology companies and his in-depth knowledge of our business. |
| 2022-03-09 | Dr. Kostas is a director affiliated with Innoviva and has medical credentials, no software-related skills indicated. |
| 2022-10-17 | Dr. Kostas has a B.S from Massachusetts Institute of Technology (MIT) and a M.D. from University of Texas Southwestern Medical School. |
| 2023-08-03 | Dr. Kostas has a B.S from Massachusetts Institute of Technology (MIT) and a M.D. from University of Texas Southwestern Medical School. |
| 2024-04-29 | Dr. Kostas has a B.S from Massachusetts Institute of Technology (MIT) and a M.D. from University of Texas Southwestern Medical School. |
Data sourced from SEC filings. Last updated: 2025-10-11